The Contribution of GWAS Loci in Familial Dyslipidemias

PLoS Genetics

Volumn 12, Issue 5, 2016, Pages

  Ripatti, Pietari ^a   Rämö, Joel T ^a,b,c   Söderlund, Sanni ^a   Surakka, Ida ^a   Matikainen, Niina ^a,d   Pirinen, Matti ^a   Pajukanta, Päivi ^e   Sarin, Antti Pekka ^a,f   Service, Susan K ^g   Laurila, Pirkka Pekka ^a,f   Ehnholm, Christian ^f   Salomaa, Veikko ^f   Wilson, Richard K ^h   Palotie, Aarno ^a,b,c   Freimer, Nelson B ^g   Taskinen, Marja Riitta ^a   Ripatti, Samuli ^a,i,j  

^a UNIVERSITY OF HELSINKI   (Finland)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ARTICLE; BODY MASS; CONTROLLED STUDY; DYSLIPIDEMIA; FAMILIAL COMBINED HYPERLIPIDEMIA; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; FEMALE; FINN (CITIZEN); GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION STUDY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; PHENOTYPE; PREDICTIVE VALUE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; BLOOD; CORONARY ARTERY DISEASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; PATHOLOGY;

ADULT; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 84974530357     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006078     Document Type: Article

References (28)

1. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG, Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52(7):1544–68. doi: 10.1172/JCI1073324718953
2. Nikkila EA, Aro A, Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet. 1973;1(7810):954–9. 4121585
3. Voors-Pette C, de Bruin TW, Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity. Atherosclerosis. 2001;157(2):481–9. 11472750
4. Genest JJ, Jr.Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85(6):2025–33. 1534286
5. European Association for Cardiovascular Prevention & RehabilitationReiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769–818. doi: 10.1093/eurheartj/ehr15821712404
6. Brahm AJ, Hegele RA, Combined hyperlipidemia: familial but not (usually) monogenic. Curr Opin Lipidol. 2015. doi: 10.1097/MOL.0000000000000270
7. Brouwers MC, van Greevenbroek MM, Stehouwer CD, de Graaf J, Stalenhoef AF, The genetics of familial combined hyperlipidaemia. Nat Rev Endocrinol. 2012;8(6):352–62. doi: 10.1038/nrendo.2012.1522330738
8. Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, et al. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2011;31(8):1916–26. doi: 10.1161/ATVBAHA.111.22636521597005
9. Talmud PJ, Shah S, Whittall R, Futema M, Howard P, Cooper JA, et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet. 2013;381(9874):1293–301. doi: 10.1016/S0140-6736(12)62127-823433573
10. Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014;2(8):655–66. doi: 10.1016/S2213-8587(13)70191-824731657
11. Stitziel NO, Peloso GM, Abifadel M, Cefalu AB, Fouchier S, Motazacker MM, et al. Exome sequencing in suspected monogenic dyslipidemias. Circ Cardiovasc Genet. 2015;8(2):343–50. doi: 10.1161/CIRCGENETICS.114.00077625632026
12. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002;11(24):3039–46. 12417525
13. Zhao SP, Smelt AH, Van den Maagdenberg AM, Van Tol A, Vroom TF, Gevers Leuven JA, et al. Plasma lipoprotein profiles of normocholesterolemic and hypercholesterolemic homozygotes for apolipoprotein E2(Arg158—>Cys) compared. Clin Chem. 1994;40(8):1559–66. 8044997
14. Brunzell JD, Zambon A, Deeb SS, The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta. 2012;1821(3):365–72. doi: 10.1016/j.bbalip.2011.09.00821986251
15. Hegele RA, Vezina C, Moorjani S, Lupien PJ, Gagne C, Brun LD, et al. A hepatic lipase gene mutation associated with heritable lipolytic deficiency. J Clin Endocrinol Metab. 1991;72(3):730–2. doi: 10.1210/jcem-72-3-7301671786
16. Vuorio AF, Aalto-Setälä K, Koivisto UM, Turtola H, Nissen H, Kovanen PT, et al. Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences Finnish FH-group. Ann Med. 2001;33:410–21. 11585102
17. Calandra S, Priore Oliva C, Tarugi P, Bertolini S, APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol. 2006;17(2):122–7. doi: 10.1097/01.mol.0000217892.00618.5416531747
18. Jarvik GP, Brunzell JD, Austin MA, Krauss RM, Motulsky AG, Wijsman E, Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler Thromb. 1994;14(11):1687–94. 7947591
19. van Greevenbroek MM, Stalenhoef AF, de Graaf J, Brouwers MC, Familial combined hyperlipidemia: from molecular insights to tailored therapy. Curr Opin Lipidol. 2014;25(3):176–82. doi: 10.1097/MOL.000000000000006824811296
20. Lewis GF, Xiao C, Hegele RA, Hypertriglyceridemia in the genomic era: a new paradigm. Endocr Rev. 2015;36(1):131–47. doi: 10.1210/er.2014-106225554923
21. Porkka KV, Nuotio I, Pajukanta P, Ehnholm C, Suurinkeroinen L, Syvanne M, et al. Phenotype expression in familial combined hyperlipidemia. Atherosclerosis. 1997;133(2):245–53. 9298685
22. Borodulin K, Vartiainen E, Peltonen M, Jousilahti P, Juolevi A, Laatikainen T, et al. Forty-year trends in cardiovascular risk factors in Finland. Eur J Public Health. 2015;25(3):539–46. doi: 10.1093/eurpub/cku17425422363
23. Kuivenhoven JA, Hegele RA, Mining the genome for lipid genes. Biochim Biophys Acta. 2014;1842(10):1993–2009. doi: 10.1016/j.bbadis.2014.04.02824798233
24. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466(7307):707–13. Epub 2010/08/06. doi: 10.1038/nature0927020686565
25. Surakka I, Horikoshi M, Magi R, Sarin AP, Mahajan A, Lagou V, et al. The impact of low-frequency and rare variants on lipid levels. Nat Genet. 2015;47(6):589–97. doi: 10.1038/ng.330025961943
26. Global Lipids Genetics ConsortiumWiller CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274–83. doi: 10.1038/ng.279724097068
27. Pirinen M, Donnelly P, Spencer CCA, Efficient computation with a linear mixed model on large-scale data sets with applications to genetic studies. Ann Appl Stat. 2013;7(1):369–90. doi: 10.1214/12-AOAS586
28. R Core TeamR: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2014.